FOUR NEWER HORIZONS FOR THE TREATMENT OF METASTATIC RESISTANT PROSTATE CANCER

Authors

  • DR . ANITA SAMRAJ Associate professor , Department of General Surgery , Saveetha Medical College , Chennai
  • DR . V.KRISHNAN Assistant professor , Department of Pharmacology , Saveetha Medical College , Chennai

Keywords:

PROSTATE CANCER, SIPULEUCEL, CABAZITAXEL

Abstract

Prostate cancer is the second most common tumor affecting the men, ranking next to non melanoma skin cancers. It is also the second most cause of cancer mortality among men , next to neoplasm’s of the lung. Significant earlier detection, improved surveillance increases the number of cancer prostate men detection at an earlier stage and various treatment options are being tried to improve  prognosis . The objective of our article is to provide a comprehensive review of newer molecules of prostate cancer management.

Downloads

Published

30.06.2014

How to Cite

DR . ANITA SAMRAJ, & DR . V.KRISHNAN. (2014). FOUR NEWER HORIZONS FOR THE TREATMENT OF METASTATIC RESISTANT PROSTATE CANCER. International Journal of Pharma and Bio Sciences, 5(2), 466–468. Retrieved from https://ijpbs.net/index.php/journal/article/view/3493

Issue

Volume 5, Issue 2, 2014

Section

Review Articles

Categories

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.